TokenPost·

XTL Biopharmaceuticals Posts $0.00 GAAP EPS for First Half

Your call?

Cash and cash equivalents were approximately $1.80 million at June 30, 2026, up from approximately $0.08 million on Dec. 31, 2025.

Share

More news